Avencia Sanchez-Mejias PhD
236 posts
@avenciasm
CEO & Co-founder @integra_TX a global leader creating next-generation #GeneWritting tools to make #AdvanceTherapies safer #STEMWomen Yoguini, lactivist, mother
Integra Therapeutics to receive up to €10.5 million from @EU_Commission for its #FiCAT advanced therapies platform via the #eicAccelerator program: bit.ly/4cVQqaw #investment #AdvancedTherapies #GeneTherapy #GeneWriting #CRISPR
We are happy to have Paolo Petazzi as Torres Quevedo Senior Scientist at #TeamIntegra 🧬 With 12 years of experience at @CarrerasIJC and @idibell_cat, he joined Integra in 2022 and is leading our efforts in primary cell engineering with the #FiCAT platform. #talent #GeneWriting
March is an empowering month dedicated to celebrating the remarkable contributions of the incredible #women who are transforming the landscape of the #syntheticbiology industry, including the ones you can meet at #SynBioBeta2024: synbiobeta.activehosted.com/index.php?acti… #InternationalWomensDay
INVIVO III/ Thrilled to announce we are preparing the closing of III fund, aiming for €100-120M (cell & gene therapy + synthetic biology + AI). @laurg87 is now Partner. Having Laura is a privilege; she stands out as one of the most talented individuals I have ever encountered.
Spanish researchers to design proteins using #AI to make #AdvancedTherapies more efficient. Selected by @CienciaGob and @CDTI_innovacion as one of the 40 projects that address a challenge that is at the forefront of society and economy. Funded by €3.8 million. 👇🏼
En el Día Internacional de la Mujer y la Niña en la Ciencia, en D+I-EL ESPAÑOL hemos entrevistado a cuatro mujeres, junto a sus hijas, para conocer cómo han compartido el interés por estas disciplinas entre generaciones. ✍️ @beazmi y @NoeliaHn elespanol.com/invertia/disru…
Since we founded Integra Therapeutics in 2020, on #February11 we take part in the International Day of Women and Girls in Science. Every day, we are committed to leading by example of the value of women in science for the scientist of tomorrow. 50% of our team are 🧬♂
